| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |